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ABSTRACT
Pseudouridine synthase 1 (Pus1p) is an unusual
site-specific modification enzyme in that it can
modify a number of positions in tRNAs and can rec-
ognize several other types of RNA. No consensus
recognition sequence or structure has been identi-
fied for Pus1p. Human Pus1p was used to determine
which structural or sequence elements of human
tRNA
Ser are necessary for pseudouridine ()) forma-
tion at position 28 in the anticodon stem-loop (ASL).
Some point mutations in the ASL stem of tRNA
Ser
had significant effects on the levels of modification
and compensatory mutation, to reform the base
pair, restored a wild-type level of ) formation.
Deletion analysis showed that the tRNA
Ser T)C
stem-loop was a determinant for modification in
the ASL. A mini-substrate composed of the ASL
and T)C stem-loop exhibited significant ) forma-
tion at position 28 and a number of mutants were
tested. Substantial base pairing in the ASL stem (3
out of 5bp) is required, but the sequence of the T)C
loop is not required for modification. When all nu-
cleotides in the ASL stem other than U28 were
changed in a single mutant, but base pairing was
retained, a near wild-type level of modification was
observed.
INTRODUCTION
Pseudouridine () is the most abundant post-
transcriptional RNA base modiﬁcation and the enzymes
responsible for this isomerization of uridine and the pos-
itions modiﬁed in the RNAs, are conserved (1–4). This
modiﬁcation is important in the structure and function
of small RNAs (5–11), including small nuclear RNAs
(snRNAs), cofactors in pre-mRNA splicing (12–16).
There are two pathways for the formation of  in eukary-
otes. One pathway is involved in the formation of  in
rRNA and snRNA and requires Dyskerin or its homologs
(Cbf5p in yeast for example) and RNP cofactors [most
often H/ACA small nucleolar ribonucleoprotein particles
(snoRNPs)] that enable one enzyme to recognize many
different sites for modiﬁcation on different substrates
(17–25). The other pathway for  formation employs
site-speciﬁc  synthases that require no cofactors to rec-
ognize and modify the RNA substrate. A number of en-
zymes have been identiﬁed in this pathway and are
grouped in six families that all share a common basic
structure (4). It is safe to say the cofactor ‘guided’ pathway
has received a great deal of attention because of its simi-
larity to aspects of RNA editing, but the site-speciﬁc
pseudouridine synthases accomplish the same task, on
more substrates, with fewer tools, arguably making them
more interesting from an enzymatic perspective.
One of the most studied site-speciﬁc enzymes is
Pseudouridine synthase 1 (Pus1p) (26–35). Pus1p
modiﬁes uridines in several regions of many different
tRNAs (27,33,34) and one position in yeast U2 snRNA
(36). It is a transcriptional coactivator in nuclear receptor
signaling, modifying Steroid Receptor Activator RNA
(SRA) (37,38), and when mutated or missing, leads to
the disorder Mitochondrial myopathy and sideroblastic
anemia with lactic acidemia (MLASA) (39–42).
In vivo and in vitro Pus1p modiﬁes positions 1, 26,
27 and 28 in many tRNAs and positions 34 and 36 in
the anticodons of certain intron-containing tRNAs
(26–28,33). In addition, yeast Pus1p has been shown to
modify positions 65 and 67 in vivo (34) and mouse
(mPus1p) and human Pus1p (hPus1p) modify position
30 in tRNAs, whereas yeast Pus1p does not (29,33). The
presence of the intron in yeast pre-tRNA
Ile(UAU) is
required for the formation of  at positions 34 and 36
in the anticodon by Pus1p in vitro (26,34). The intron
allows for the formation of a stem that contains the
uridines to be modiﬁed (26,34,43). Residues that are modi-
ﬁed in tRNA by Pus1p are part of a base-paired stem,
suggesting RNA secondary structure is important for rec-
ognition by Pus1p (26,27,33–35). Even with all of the
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quirement) that has been proposed for Pus1p is the
presence of a pyrimidine nucleotide 30 of the site of modi-
ﬁcation (44).
Interestingly, yeast Pus1p has been shown to modify
position 44 on yeast U2 snRNA, a position that is con-
sidered to be in a non-base paired region of U2 snRNA
(36). When mouse Pus1p is expressed in a pus1 deleted
yeast strain, the mouse enzyme can also modify yeast
U2 snRNA at the same position (33). However, the modi-
ﬁcation of U2 snRNA in Caenorhabditis elegans does not
require Pus1p, since the loss of the pus-1 gene product in
worms results in the absence of  at known Pus1p modi-
ﬁcation sites on tRNA, but has no effect on the modiﬁca-
tion of U2 snRNA or other snRNAs (28,45).
Crystal structures for Pus1p have not been solved.
However, the structure of a member of the same synthase
family, bacterial TruA, in the presence of tRNA sub-
strates, has been revealed (46,47). TruA modiﬁes uridines
at positions 38–40 in many tRNAs and the equivalent
activity in eukaryotes is associated with Pseudouridine
synthase 3, another member of the TruA family [Pus3p;
(48,49)]. The substrate tRNA binds across a dimer of
TruA (46,47). The anticodon stem-loop (ASL) of the
tRNA, as well as the dihydrouridine (D) stem and
the ‘elbow’ where the D and TC loops interact, con-
tact the synthase (47). TruA did not interact with the
variable (V) stem-loop or the acceptor stem of the
tRNA substrate (47).
In order to begin to understand how Pus1p can modify
several positions in tRNAs and also modify other RNAs
such as U2 snRNA and SRA, we undertook an investiga-
tion of the sequence and structural requirements for
hPus1p activity on human tRNA
Ser. The activity of
hPus1p with wild-type and point and deletion mutants of
the tRNA substrate indicates there are structural require-
ments in the formation of  at position 28 in tRNA
Ser.A
minimum level of base pairing in the ASL (the location of
the modiﬁcation) and the presence of an additional 30
stem-loop, constitute the minimal substrate for hPus1p.
Even when all nucleotides in the ASL stem other than
U28 were changed in a single minimal substrate, but
base pairing was retained, a near wild-type level of modi-
ﬁcation was observed.
MATERIALS AND METHODS
Isolation of recombinant hPus1p and site directed
mutagenesis of tRNA
Ser
Recombinant hPus1p was expressed and isolated as de-
scribed (29). Site-directed mutagenesis of human
tRNA
Ser (UGA) was performed with a Quikchange II
kit (Stratagene), utilizing primers containing the muta-
tions and the pHtS plasmid [human tRNA
Ser(UGA); gift
of H. Gross (50)] to create the mutants. The resulting con-
structs have a T7 RNA polymerase promoter at the 50-end
of the tRNA gene and a BstN1 site at the 30-end of the
gene. Plasmid DNA digested with BstN1 will yield tRNAs
with CCA at the 30-terminus after transcription (29,50).
The primers used for mutagenesis are given below with
just the forward primers listed; the reverse primers are
the inverse complement. The forward primer for:
27C was 50CGAGTGGTTAAGGCGCTGGACTTGAA
ATCCA,
27G was 50CGAGTGGTTAAGGCGGTGGACTTGAA
ATCCA,
28C was 50GAGTGGTTAAGGCGACGGACTTGAAA
TCC used with the 42G mutant to create 28C/42G,
29C was 50GAGTGGTTAAGGCGATCGACTTGAAA
TCCATT,
30C was 50GTGGTTAAGGCGATGCACTTGAAATC
CATTG,
31C was 50GTGGTTAAGGCGATGGCCTTGAAATC
CATTGG,
39G was 50CGATGGACTTGAAAGCCATTGGGGTC,
40G was 50GATGGACTTGAAATGCATTGGGGTCTC,
41G was 50GACTTGAAATCGATTGGGGTCTCC,
and used in the 29C/41G mutant starting with 29C
template,
42C was 50GGACTTGAAATCCCTTGGGGTCTCC,
42G was 50GGACTTGAAATCCGTTGGGGTCTCC,
43G was 50GGACTTGAAATCCAGTGGGGTCTCC,
and used in the 27C/43G mutant starting with 27C
template and in 27G/43G mutant starting with the
27G template,
30C/40G was 50GATGCACTTGAAATGCATTGGGG
TCTC, starting with the 30G template,
31C/39G was 50CGATGGCCTTGAAAGCCATTGGG
GTC, starting with the 31C template,
 D stem-loop was 50GTAGTCGTGGCGATGGACTT
GAAATCC,
 D stem-loop with 28C/42G was 50GTAGTCGTGGC
GACGGACTTGAAATCCGTTGGGGTCTCCCC.
RNA synthesis, the tritium-release assay and binding
assays
The digested plasmid DNAs were transcribed with T7
RNA polymerase in the presence of 25mCi [5-
3H]-UTP
(11.1 or 23.9Ci/mmol, Moravek) or 25mCi [5,6-
3H]-UTP
(38Ci/mmol, Moravek) with 100mM cold UTP and
1.0mM, non-labeled, ATP, GTP and CTP (51).
Additional RNA substrates were synthesized using a
sense T7 DNA oligonucleotide, an antisense template
oligonucleotide and high concentration T7 RNA
Polymerase, as described (52,53). The oligodeoxynu-
cleotides used for this type of synthesis are listed below,
note that the oligodeoxynucleotides that serve as the tem-
plate for synthesis are antisense and have antisense T7
primer sequence at the 30-end.
The T7 primer used was 50TAATACGACTCACTATAG.
The template for the:
ASL stem-loop was 50AATGGATTTCAAGTCCATCT
ATAGTGAGTCGTATTA,
ASL & D stem-loops was 50ATGGATTTCAAGTCCAT
CGCCTTAACCACTCGGCTATAGTGAGTCGT
ATTA,
ASL & V stem-loops was 50GGGGAGACCCCAATGG
ATTTCAAGTCCATCTATAGTGAGTCGTATTA,
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CTGCGCGGGGAGACCCCAATGGATTTCAAGT
CCATCTATAGTGAGTCGTATTA,
ASL, D, & V stem-loops was 50GGGGAGACCCCAAT
GGATTTCAAGTCCATCGCCTTAACCACTCGGC
TATAGTGAGTCGTATTA,
ASL, D, V, & TC stem-loops was 50GCAGGATTCGA
ACCTGCGCGGGGAGACCCCAATGGATTTCAA
GTCCATCGCCTTAACCACTCGGCTATAGTGAG
TCGTATTA,
 TC stem-loop was 50TGGCGTAGTCGGCGCGGG
GAGACCCCAATGGATTTCAAGTCCATCGCCTT
AACCACTCGGCCACGACTACTATAGTGAGTC
GTATTA,
 V stem-loop was 50 TGGCGTAGTCGGCAGGATTC
GAACCTGCGAATGGATTTCAAGTCCATCGCCT
TAACCACTCGGCCACGACTACTATAGTGAGTC
GTATTA.
ASL & TC stem-loop mini-substrate required the fol-
lowing oligodeoxynucleotide template: 50GCAGGATT
CGAACCTGCGCCAATGGATTTCAAGTCCATCT
ATAGTGAGTCGTATTA. The small size of this
mini-substrate and the fact that the ﬁrst nucleotide
transcribed is a ‘G’, allows for efﬁcient synthesis of
RNAs in vitro. The following mutations were
incorporated into the oligodeoxynucleotide template
to generate variations of the ASL & TC stem-loop
mini-substrate:
GGACG starting at 61 was 50CGTCCATTCGAACCTG
CGCCAATGGATTTCAAGTCCATCATAGTGAGT
CGTATTA,
AAGCUUA in TC loop was 50GCAGGTAAGCTTCC
TGCGCCAATGGATTTCAAGTCCATCATAGTGA
GTCGTATTA,
28C/42G was 50GCAGGATTCGAACCTGCGCCAAC
GGATTTCAAGTCCGTCTATAGTGAGTCGTAT
TA,
27C/39G was 50GCAGGATTCGAACCTGCGCCAAT
GGCTTTCAAGTCCAGCTATAGTGAGTCGTAT
TA,
27C/42C was 50GCAGGATTCGAACCTGCGCCAAG
GGATTTCAAGTCCAGCTATAGTGAGTCGTAT
TA,
27C/29C/39G was 50GCAGGATTCGAACCTGCGCCA
ATGGCTTTCAAGTCGAGCTATAGTGAGTCGT
ATTA,
27C/39G/40G was 50GCAGGATTCGAACCTGCGCCA
ATGCCTTTCAAGTCCAGCTATAGTGAGTCGTA
TTA,
27C/29C/42G was 50GCAGGATTCGAACCTGCGCCA
AGGGATTTCAAGTCGAGCTATAGTGAGTCGT
ATTA,
27C/29C/39G/40G was 50GCAGGATTCGAACCTGCG
CCAATGCCTTTCAAGTCGAGCTATAGTGAGTC
GTATTA,
27C/29C/39G/40G/42C was 50GCAGGATTCGAACCT
GCGCCAAGGCCTTTCAAGTCGAGCTATAGTG
AGTCGTATTA,
55 & 56 was 50GCAGGATTCACCTGCGCCAATGG
ATTTCAAGTCCATCTATAGTGAGTCGTATTA,
55–58 was 50GCAGGATACCTGCGCCAATGGATT
TCAAGTCCATCTATAGTGAGTCGTATTA,
GCAA inserted after 55 was 50GCAGGATTCGTTGCA
ACCTGCGCCAATGGATTTCAAGTCCATCTATA
GTGAGTCGTATTA,
Y for Y R for R stem mini-substrate mutant was 50GCA
GGATTCGAACCTGCGCCAGCAAGTTTCAAGC
TTACCTATAGTGAGTCGTATTA.
Before incubation with hPus1p, the RNA substrates
were heated to 78 C for 3min and allowed to cool slowly
to at least 37 C (30–40min). Substrate reactions with the
 synthases were carried out in 50mM ammonium chlor-
ide, 5mM DTT, 25mM Tris (pH 7.5) and 1mM MgCl2.
The amount of  synthase used was  200ng at 37 C for
the times indicated.
The tritium-release assay is described in detail elsewhere
(54,55). Brieﬂy, it involves mixing the previously incu-
bated reaction with Norit A charcoal. Norit A charcoal
binds all of the
3H counts in the sample except those that
have been ‘released’ to water in the process of forming .
The released counts are separated from the charcoal-
bound counts using a SPIN-X column (Costar), the
ﬁltrate is mixed with scintillation ﬂuid, and the released
3H counts are measured on a scintillation counter.
The equilibrium binding assays were carried out as
described (32) using hPus1p concentrations of 0, 50, 100,
200, 400 and 800nM in 50ml reactions, with the
3H-labeled RNA substrates at 500pM. The RNAs were
synthesized as described above except that the cold UTP
concentration in the synthesis reaction was 250mM. A
slot-blot apparatus (BioRad) was used for ﬁltration of
the samples, the resulting ﬁlters were air dried, cut into
appropriate pieces and counted in scintillation ﬂuid.
RESULTS
As an initial investigation into the substrate requirements
for hPus1p, it was important to choose a known Pus1p
substrate tRNA that has only one site modiﬁed by the
enzyme (29,35), to simplify the analysis of the activity. A
tRNA that is typical in structure and has a V stem-loop
that was >6nt, was preferred in order to be able to test the
contribution of all structural components to substrate rec-
ognition by hPus1p. In addition, a tRNA with traditional
Watson-Crick base-pairing in the ASL stem was desired.
The tRNA sequence database, tRNAdb (56,57), was con-
sulted to compile consensus sequences for the ASL stem
where a  or U is found at position 28 in sequenced
tRNAs from the fungi and metazoan group in tRNAdb.
At least 36 tRNA sequences were compiled to generate
each consensus shown in Figure 1B. Several features are
apparent in these two stems. First, with a  at position 28,
G30–C40 is the most conserved base pair (>90%
conserved) but when a U is found at position 28, this se-
quence is not as well conserved. Therefore, one might ex-
pect that disruption of this base pair or replacement with
the inverse (C30–G40) will affect modiﬁcation. Second,
for sequenced tRNAs that have a  at 28, the preferred
27–43bp is U27–A43, whereas with those tRNAs with a
U at 28, the preferred base pair is C27–G43. Third, a
Nucleic Acids Research,2012, Vol.40, No. 5 2109A31–U39 base pair is more common in those ASL stems
that have a  at position 28 than those with a U at
position 28. Finally, the base pairs 29–41 and 31–39,
below the 28–42bp, are Watson-Crick only but the rest
of the base pairs in the stem can have G-U pairing in
either consensus. In the selection of a tRNA, a good
match to this consensus was preferred, and human
tRNA
Ser(UGA) meets most of the criteria. The only dif-
ference is that this tRNA has an A27–U43 base pair
instead of a U–A base pair at that position (Figure 1A).
The point mutations in the ASL of full-length tRNA
Ser
are diagrammed in Figure 2H and were obtained by site-
directed mutagenesis of the plasmid containing wild-type
human tRNA
Ser [pHtS, gift from H. Gross; (50)] followed
by in vitro transcription of linear templates (see ‘Materials
and Methods’ section). Time course analyses of the in vitro
activity of the substrate RNAs and hPus1p are presented
in Figure 2 (panels A–G), with the same wild-type
tRNA
Ser curve in all panels (Figure 2A–G). The formation
of  in this tRNA by hPus1p is reduced to background
levels (0.02mol /mol RNA) if the U at position 28 is
changed to C and A42 is changed to G to preserve base
pairing (Table 2, second experiment). This shows that the
only U converted to  by hPus1p is the one at position 28.
The panels in Figure 2 each contain the wild-type tRNA
Ser
curve and either two or three curves generated with
tRNA
Ser mutant substrates. This style allows for a simpli-
ﬁcation of the presentation and for the focus in most
panels to be on 1bp at a time.
When the A at 27 is changed to C or G (Figure 2A), the
levels of  formed are not signiﬁcantly different from
wild-type tRNA
Ser. The curve that results when the U at
43 is changed to G is distinct from the wild-type tRNA
Ser
curve but the difference is not statistically signiﬁcant
because of the relatively large error bars (SD).
Mutation of the A at the position across from U28 to
either C or G has little effect on time course of  formed
(Figure 2B). Even though the A at position 42 is preferred
(Figure 1B), the formation of 28 does not require canon-
ical or even U–G base pairing, something unanticipated
given the consensus sequence (Figure 1B).
When G29 is changed to C or C41 is changed to G
(Figure 2C), there is a signiﬁcant decrease in  formation
for both mutations in the formation of  at 28. However,
when the base pair is reformed, but is now C-G in the
case of the double mutant 29C/41G, the curve obtained
is indistinguishable from that of wild-type tRNA
Ser
(Figure 2F). This introduction of a base-paired pyrimidine
30 to U28 did not enhance the formation of  in the sub-
strate, an expectation if a pyrimidine is preferred at
position 29, as suggested in the Introduction.
The consensus sequence shown in Figure 1B revealed
the G30–C40 base pair to be highly conserved in the puta-
tive Pus1p substrates with a  at position 28. It was
expected that disruption of this base pair would affect
the formation of  by hPus1p. In fact, the 30C and 40G
mutants have signiﬁcantly lower amounts of  formed
than wild-type tRNA
Ser (Figure 2D). If the base pair is
reformed but inverted, as with the 30C/40G double
mutant, the time course of  formed is the same as that
of wild-type tRNA
Ser (Figure 2F). This result argues
against the requirement for a G at position 30, even
though the 28 consensus suggests it (Figure 1B).
When the base pair at A31–U39 is disrupted by either
the 31C or 39G point mutations, the results are interest-
ing. The curve of  formation seen with the 31C sub-
strate is signiﬁcantly different from wild-type tRNA
Ser
(Figure 2E), but with the 39G mutant the curve mimics
that seen with wild-type tRNA
Ser (Figure 2E). Reforming
the base pair with the 31C/39G double mutant results in a
curve that matches that of wild-type tRNA
Ser (Figure 2F).
A
B
Figure 1. Human tRNA
Ser(UGA) sequence and secondary structure
and ASL stem consensus sequence. (A) The sequence and proposed
secondary structure of Human tRNA
Ser(UGA) (50). The major
aspects of the secondary structure are labeled on the diagram and
it is numbered without including most of the Variable stem-loop. The
single site of Pus1p modiﬁcation, position 28, is boxed. (B) Consensus
sequences for sequenced tRNAs from the fungi and metazoa group in
the tRNAdb (57) that have a  or a U at position 28. The ﬁgure is
presented in the output style from tRNAdb. A solid line between nu-
cleotides indicates Watson-Crick pairs only and a dash line indicates
G–U pairs (<50%) are also found at this position.
2110 Nucleic Acids Research, 2012,Vol.40, No. 5The only difference between the 28 consensus stem
(Figure 1B) and the stem of the tRNA
Ser (Figure 1A) is
the 27–43bp, which is A–U in tRNA
Ser. The  formation
curves for the 27C, 27G and 43G mutants were not sig-
niﬁcantly different from wild-type tRNA
Ser (Figure 2A).
This would suggest that the enzyme does not require a
base pair at 27–43, and may in fact be indifferent to the
presence of a base pair. That statement was supported by
the  formation curve seen with the 27G/43G double
mutant, which was not signiﬁcantly different from the
curve seen with wild-type tRNA
Ser (Figure 2G), even
though there is no canonical base pair formed. The
results with the double mutant 27C/43G, which would
form a stronger base pair than the wild-type A–U, are
Figure 2. Time course experiments with single and double mutants in the ASL of human tRNA
Ser.( A–G),
3H-labeled RNAs were incubated with
hPus1p for the times indicated and the amount of  formed assayed. Each panel has the same time course of wild-type (wt) tRNA
Ser values. Each
mutant is plotted separately and standard deviation (SD) bars are displayed for all time points. (H) Diagram of ASL point mutations made in the
context of full-length tRNA
Ser that are presented in panels A–G.
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Ser
(Figure 2G) even though this mutant now mimics the
U28 consensus in Figure 1B.
Equilibrium dissociation constants (Kd) were deter-
mined for wild-type tRNA
Ser and the single-
and double-mutant substrates found in the panels of
Figure 2. The means and standard deviations of two
separate Kd determinations are presented in Table 1 and
that of wild-type tRNA
Ser (240nM) agrees with a previous
determination of the Kd (250nM) of hPus1p and yeast
pre-tRNA
Ile (29). All of the mutants have a higher mean
Kd than wild-type, with all but 41G and 43G >300nM.
There is not a correlation between the  formation levels
and the Kds for the mutants. It is interesting to note that a
tRNA that is not a substrate for hPus1p, such as the 28C/
42G double mutant, binds to the enzyme with a mean Kd
of 332nM. This was also as seen previously with yeast
Pus1p and a non-substrate tRNA (31).
In order to identify additional recognition elements of
the hPus1p substrate, stem or stem-loop deletions of, and
mini-substrates derived from tRNA
Ser, were tested in the
 formation assay. These mutant substrates were gene-
rated either by site-directed mutagenesis of pHtS and sub-
sequent in vitro transcription or by in vitro transcription
using oligodeoxynucleotide templates [see ‘Materials and
Methods’ section; (53)]. It is understood that, with the de-
letion of whole stem-loops or the creation of mini-
substrates, the tertiary structure of the entire tRNA is
affected, but surprisingly, many of these mutants can
function as substrates for hPus1p. The results for
120min incubations are listed in Table 2 relative to the ac-
tivity seen with wild-type tRNA
Ser. If the D stem-loop is
missing in the substrate, there is no decrease in hPus1p
activity at position 28. If the U at position 28 in the D
stem-loop mutant is changed to C (and the A at 42 is
changed to G) so that  cannot be formed at position
28, there is essentially no  formation (2% of wild-type
tRNA
Ser  formation, see Table 2). This result indicates
the level of  formation seen with the D stem-loop
mutant is not due to  formation at an additional site
created by an altered secondary structure in the deletion
mutant. If the TC stem-loop is missing from the tRNA,
there is a signiﬁcant reduction in the formation of  at
U28 (15% of wild-type tRNA
Ser levels, Table 2) but the
reduction is not as substantial when the V stem-loop is
missing (67% of wild-type, Table 2).
When a mini-substrate of just the ASL stem-loop was
incubated with hPus1p,  formation was at back-
ground levels for 2h of incubation (3% of wild-type
levels, Table 2). In addition, if either the D stem-loop or
the V stem-loop was combined with the ASL stem-loop,
Table 2. Activity of hPus1p on tRNA
Ser(UGA) point and deletion mutants and mini-substrates
RNA substrate mole /mole
RNA (SD)
a
Percent of
wild-type (SD)
Wild-type human tRNA
Ser 0.60 (0.08) 100 (13)
 TC stem-loop (deleted nucleotides 59–73) 0.09 (0.05) 15 (8)
 Variable stem-loop (deleted nucleotides 45–56) 0.40 (0.08) 67 (13)
Wild-type human tRNA
Ser 0.43 (0.07) 100 (16)
28C/42G (no  formation expected) 0.02 (0) 5 (0)
 D stem-loop (deleted nucleotides 11–24) 0.44 (0.16) 102 (37)
 D stem-loop with 28C/42G 0.01 (0.01) 2 (2)
Wild-type human tRNA
Ser 0.68 (0.02) 100 (3)
ASL stem loop alone (includes nucleotides 26–43) 0.02 (0.01) 3 (1)
ASL & D stem-loops (includes nucleotides 10–43) 0.07 (0.01) 10 (1)
ASL & V stem-loops (includes nucleotides 26–47) 0.05 (<0.01) 7 (1)
ASL, D, & V stem-loops (includes nucleotides 10–47) 0.14 (<0.01) 21 (1)
ASL, V, & TC stem-loops (includes nucleotides 26–65) 0.48 (0.04) 71 (6)
ASL, D, V, & TC stem-loops (includes nucleotides 7–65) 0.64 (0.16) 94 (24)
aActivities are from 2-h incubations, an average of two assays, with duplicate samples, and reported as mol /mol RNA and as the
percent of the level seen with wild-type tRNA
Ser(UGA) with the standard deviation (SD) also reported as percent of wild-type. These
results are grouped as separate experiments with a separate wild-type control for each experiment.
Table 1. Equilibrium dissociation constants (Kd) of hPus1p with
various RNAs
RNA substrate Kd Mean (SD)
a
Wild-type tRNA
Ser 240 (14)nM
Single point mutants in tRNA
Ser
27C 328 (46)nM
27G 370 (14)nM
29C 408 (11)nM
30C 335 (120)nM
31C 358 (53)nM
39G 380 (28)nM
40G 305 (49)nM
41G 282 (18)nM
42C 360 (57)nM
42G 338 (46)nM
43G 248 (32)nM
Double mutants in tRNA
Ser
27C/43G 302 (39)nM
27G/43G 375 (7)nM
28C/42G 332 (18)nM
29C/41G 328 (74)nM
30G/40C 345 (21)nM
31C/39G 315 (92)nM
aListed are the means and standard deviations (SD) of two separate
binding experiments of hPus1p and the substrates listed (see ‘Materials
and Methods’ section for details).
2112 Nucleic Acids Research, 2012,Vol.40, No. 5there was little increase in the amount of  formed (10%
and 7%, respectively, of the  formation seen in 120min
with wild-type tRNA
Ser, Table 2). This implies that adding
a single stem-loop to the 50 or 30 side of the ASL stem-loop
does not constitute an efﬁcient substrate for hPus1p. If
both the D and V stem-loops are added to the ASL
stem-loop there is a noticeable increase in  formed but
it is still low (21%) compared to wild-type tRNA
Ser. When
the TC stem-loop was combined with the V and ASL
stem-loops, there was a substantial level of hPus1p activity
(71% of wild-type tRNA
Ser levels of ). With just the
acceptor stem missing from tRNA
Ser (ASL, D, V and
TC stem-loops present), the activity is essentially the
same as with wild-type tRNA
Ser (94% of wild-type  for-
mation at 120min, Table 2).
These results suggest that the secondary structure of the
tRNA
Ser is very important for the modiﬁcation at position
28, and a minimal substrate could be created by simply
connecting the ASL and TC stem-loop as diagrammed
(Figure 3A). The numbering on the diagram is consistent
with full-length tRNA
Ser to allow comparisons with the
results reported in Figure 2 and Table 2. The level of 
formation at position 28 in this minimal substrate (wild-
type ASL & TC mini-substrate) was  0.60mol /mol
RNA after 2h of incubation, a substantial level of modi-
ﬁcation (Table 3). A mini-substrate incorporating a 28C/
42G double mutation was used in a separate experiment
with little or no  formation observed (Table 3), providing
evidence that in this mini-substrate, the U at position 28 is
the only one being converted to , as expected.
Concentrating on the ASL stem, a number of mutant
substrates were synthesized that pick up where the previ-
ous mutations in the full length tRNA (Figure 2 and
Table 2) left off. The ASL stem of tRNA
Ser has ﬁve
Watson-Crick base pairs and the mini-substrate mutants
listed in Table 3 were designed to eliminate two or more of
those base pairs in each mutant. The base pairs that may
still form in each mutant are diagrammed in Figure 3B
and the levels of activity, as a percentage of the activity
observed with the wild-type ASL & TC mini-substrate,
are given in Table 3 and Figure 3B. When there is no
base-pairing in the stem there is little formation of ,
and the possibility of 1 or even 2bp in the stem, does
not substantially elevate the amount of  formed.
However, with the 27C/42C mutant substrate, which has
3bp in the stem below the site of modiﬁcation, 80% of the
 level seen with the wild-type ASL & TC mini-substrate
was observed. The level of  formation by hPus1p on the
27C/39G mutant substrate was only 40%, even though it
too has 3bp in the stem.
With respect to the TC stem-loop, if the nucleotides
at 55 and 56 are deleted in this ASL & TC mini-
substrate, there is a decrease in  formation relative
to the wild-type ASL & TC mini-substrate (62% of
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Figure 3. ASL & TC stem-loop mini-substrate and mutations. (A) Predicted structure of the ASL & TC stem loop mini-substrate, retaining the
numbering found on the full-length tRNA
Ser and indicating the position of the  formed. The structure for the Y for Y R for R stem mini-substrate
mutant and the C28 mutant are also shown. (B) Diagram of the possible base pairing in the ASL stem mutants in the mini-substrate listed in Table 3.
The activities in percent of the level observed with wild-type ASL & TC stem-loop mini-substrate without the SD are listed above the diagrams.
The mutations found in each stem are listed below the diagrams.
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Ser, Table 3). If the size of the TC loop is
reduced further (55–58) the resulting substrate is a poor
one, just 28% of wild-type levels of  were observed
(Table 3). If 4nt (GCAA) are inserted into the TC
loop to make it larger, the substrate still allows for a
signiﬁcant amount of  to be formed (77% of
wild-type ASL & TC mini-substrate levels). In a
separate experiment, if Watson-Crick base-pairing is dis-
rupted in the TC stem, with the sequence GGACG
starting at nucleotide 61, the level of hPus1p activity
was also substantial (73% or wild-type ASL & TC
mini-substrate levels), suggesting a stem loop is not
required. If the sequence of the TC loop was replaced
with its complement (AAGCUUA), the amount of 
formed at position 28 was 113% of wild-type ASL &
TC mini-substrate levels, suggesting that any loop of
at least 5nt will sufﬁce.
To summarize the results from the mutation and dele-
tion studies, the levels of  formation with the single and
double mutants in the context of the full-length tRNA
Ser
suggest that the sequence of the ASL stem is not an abso-
lute determinant of hPus1p activity, except of course that
there must be a U at position 28 to modify (Tables 2 and 3).
The preference for a pyrimidine 30 to the site of modiﬁ-
cation (at position 29; see ‘Introduction’ section) was not
conﬁrmed since even though the 29C single mutant
showed a decreased amount of  formed and the
double mutant 29C/41G exhibited an almost identical
curve as wild-type tRNA
Ser, suggesting that a pyrimidine
is not preferred, only the base pair. The point mutations
in full-length tRNA
Ser show that the base pairing below
the modiﬁed position (U28) affects  formation, whereas
the 27A–U43 base pair is dispensable. In addition, the
modiﬁed U28 does not need to participate in base pairing.
The results with the ASL & TC stem loop mini-
substrate mutants also showed that the base pairs below
U28 were the most critical. The sequence of the stem nu-
cleotides is of less importance than the presence of base
pairs, which agrees with the fact that known substrates
of Pus1p exhibit no absolute sequence requirement
(26,27,33–35). In terms of the requirements for a particu-
lar secondary structure of tRNA
Ser, the D-stem loop and
acceptor stem are dispensable for  formation at U28. In
fact, a single stem loop, 30 to the ASL, is all that is
required for substantial  formation at position 28.
The sequence, and possibly the structure of this addition-
al RNA, is not constrained.
Given the above summary of the mutation experiments,
a mini-substrate where all of the nucleotides in the ASL
stem have been changed, except of course for the U at
position 28 which is modiﬁed, should be a substrate for
hPus1p. A substrate ﬁtting this description (Figure 3A),
along with another where the U at position 28 was
changed to C, were incubated with hPus1p and assayed
for activity. The Y for Y R for R stem mini-substrate
mutant has A replaced by G, G replaced by A, C
replaced by U, and U replaced by C when compared
with the wild-type ASL & TC mini-substrate, except at
position 28. The 28C mutant has complete replacement of
the stem sequence, and should not be modiﬁed by hPus1p.
The results with these substrates, as well as with the wild-
type ASL & TC mini-substrate, are presented in Table 4
and show that this mutant is modiﬁed by hPus1p (0.33mol
/mol RNA) at 80% of wild-type levels for this experi-
ment. In addition, the 28C mutant is not modiﬁed
(0.01mol /mol RNA; 2% of wild-type levels), proving
that only the U at position 28 is modiﬁed. So, even though
all the ASL stem nucleotides in the mutant are different
from the wild-type tRNA
Ser ASL stem, and there is a
U28–G42 base pair in the mutant, the U at position 28
is converted to  at near wild-type levels.
DISCUSSION
A number of studies have determined the sites in tRNAs
that are modiﬁed by Pus1p (26,27,29,33,34). Yeast and
Table 3. Activity of hPus1p on the wild-type ASL & TC stem-loop mini-substrate and mutants
RNA substrate mole /mole
RNA (SD)
a
mole /mole
RNA (SD)
Percent of
wild-type (SD)
wild-type ASL & T)C stem-loop mini-substrate 0.60 (0.11) 0.54 (0.16) 100 (18) (30)
28C/42G (no U at expected site of  formation) 0.01 (0.01) 2 (2)
27C/42C 0.48 (0.04) 80 (7)
27C/39G 0.24 (0.05) 40 (8)
27C/29C/39G 0.10 (0.03) 17 (5)
27C/29C/42C 0.04 (0.01) 7 (2)
27C/39G/40G <0.01 (0.01) 2 (2)
27C/29C/39G/40G 0.02 (0.03) 3 (5)
27C/29C/39G/40G/42C 0.02 (<0.01) 3 (2)
55 & 56 0.37 (0.10) 62 (17)
55–58 0.17 (0.06) 28 (10)
GCAA inserted between 55 and 56 0.46 (0.04) 77 (7)
wild-type ASL & T)C stem-loop mini-substrate 0.30 (0.04) 100 (13)
GGACG starting at 61 0.22 (0.03) 73 (10)
AAGCUUA in TC loop 0.34 (0.04) 113 (13)
aActivities are from 2-h incubations, an average of two assays with duplicate samples, and reported as mol /mol RNA and as
the percent of the level seen with wild-type ASL & TC stem loop mini substrate, with the standard deviation (SD) also
reported as percent of wild-type. These results are grouped as separate experiments with separate controls for each experiment.
All of the listed mutants are in the context of the ASL & TC stem-loop mini-substrate.
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in vivo and in vitro, the enzymes are responsible for the
formation of  at positions 27 and 28 in many tRNAs, at
34 and 36 in certain intron containing tRNAs, and at
position 1 in a few substrates (29,33,34). The yeast
enzyme can also modify uridine at positions 26, 65 and
67 in vivo but not in vitro (34). When the mouse enzyme
was expressed in a Dpus1 yeast strain, position 26 was
not modiﬁed, and the modiﬁcation states of positions
65 and 67 were not determined (33). Sequenced human
tRNAs do not have  at positions 26, 65, or 67 (58),
so it is unlikely mPus1p or hPus1p exhibit activity at
these sites in vivo. The mammalian enzymes do modify
position 30 in a few tRNAs but the yeast enzyme lacks
this activity (29,33).
For the purposes of the discussion of the current results,
the modiﬁcation at positions 27 and 28 will be considered,
since these are formed in vitro in a number of substrates by
the mammalian enzymes (27,33,35). Nearly all (17 out of
18) of the sequenced yeast and human tRNAs that have a
U at position 27 have converted it to  (58). However, in
the six sequenced yeast tRNAs that have a U at position
28, the three that have a 27C–43G base pair lack  at
position 28, whereas, the other three have a 27–43A
base pair and a  at position 28 (58). This completely
agrees with the two consensus sequences shown in
Figure 1B. In the sequenced human tRNAs with a U at
28 (eight total) this correlation does not hold up complete-
ly. Three of the tRNAs have a 27–43A base pair, two
have a  at position 28, but one does not. A human tRNA
with an 27A–43U base pair does have a  at position 28
(58), suggesting that an U–A or A–U base pair at 27–43
allows for  formation at 28, whereas a 27C–43G base
pair is not conducive to  formation at position 28.
However, with the four remaining tRNAs, which have a
27C–43G base pair, two have a  at position 28 and two
do not (58). The current ﬁnding that the loss of base
pairing at, or the presence of, a C–G base pair at 27–43
does not signiﬁcantly affect the formation of  at position
28 in tRNA
Ser, correlates with the data from human
tRNAs. Human mitochondrial tRNA
Lys is known to be
a substrate of hPus1p in vivo (41) but the sequence of the
stem only matches the 28 consensus at the 27–43 and
28–42bp. Finally, the Y for Y R for R stem mini-substrate
mutant is an efﬁcient substrate for hPus1p in vitro,
even though the sequence in the stem does not match
the consensus at any position except 28 (Figure 3A and
Table 4). There must be other determinants allowing for
or suppressing  formation in these other tRNAs with a
U at 28.
The uridine to be modiﬁed does not have to participate
in Watson-Crick base-pairing but nucleotides participat-
ing in base-pairing 30 to the modiﬁed position appear to be
required to constitute an efﬁcient substrate. These results
correlate well with the observation that, in vivo, yeast
Pus1p formed  at position 26 in yeast tRNA
Trp(CCA),
where the uridine is in the hinge between the D stem-loop
and the ASL, and is followed by 5bp in the ASL stem
(33). In addition, both yeast and mouse Pus1p modify the
uridine in position 1 on yeast tRNA
Arg(ACG), with base
pairing present in the acceptor stem 30 to the position of
modiﬁcation (33). And ﬁnally, yeast and mammalian
Pus1p modiﬁes several uridines in the extensively
base-paired ASL of yeast pre-tRNA
Ile(UAU) in vitro
and in vivo (27,29,33).
The lack of a strict substrate sequence requirement for
hPus1p can be contrasted with the rigid recognition motif
of yeast Pseudouridine synthase 7 (Pus7p), another syn-
thase that can recognize more than one site in tRNA and
other types of RNA (44). With Pus7p there is an absolute
requirement for a U at  2 and an A at+1 relative to the
uridine modiﬁed (44). Of the sequenced yeast and human
tRNAs, all that have the proscribed Pus7p recognition
sequence (17 total) have a  at position 13 or 35 (58).
The other site-speciﬁc  synthases modify only one site
in tRNAs (Pseudouridine synthases 4/10, 6, 8/9) or one
small region in many tRNAs (Pus3p) (48,49,59–62). With
these latter  synthases the local tRNA structure appears
to be a determining factor for substrate recognition when
one considers the results of TruA (Pus3p homolog) and
TruB (Pseudouridine synthase 4 homolog) structural
studies (46,47,63,64).
Given the requirement that the uridine to be modiﬁed
be in a base-paired stem, why is the uridine at position 44
in yeast U2 snRNA modiﬁed by Pus1p (33) when that
position is not considered to be in a region that is base
paired? Yeast Pus1p can modify U2 snRNA in vitro and
in vivo, but mPus1p only modiﬁes U44 on U2 snRNA
in vivo,i napus1 strain (33,36). An alternative structure,
perhaps in the ribonucleoprotein particle where U44 is
base-paired, may form in vivo. It is also possible that
another RNA, such as a snoRNA, base pairs in the region
of U44 and forms a stem that can be recognized by yeast
or mouse Pus1p. It is interesting to note that  formation
in U2 snRNA in C. elegans is not dependent on Pus1p
activity (28).
The results with mutations in the TC stem-loop
suggest that there is a minimum size requirement for
this loop but the actual sequence, or base pairing in the
Table 4. Activity of hPus1p with wild-type ASL & TC stem-loop
mini-substrate and stem sequence mini-substrate mutants
RNA substrate mole /mole
RNA (SD)
a
Percent of
wild-type (SD)
Wild-type ASL & T)C stem-loop
mini-substrate
0.41 (0.05) 100 (12)
Y for Y R for R stem
mini-substrate mutant 27G/29A/
30A/31G/39C/40U/41U/42G/
43C
0.33 (0.02) 80 (5)
Y for Y R for R stem
mini-substrate 28C mutant 27G/
28C/29A/30A/31G/39C/40U/
41U/42G/43C
0.01 (0.01) 2 (2)
aActivities are from 2-h incubations, an average of three separate
assays, and reported as mol /mol RNA and as the percent of the
level seen with wild-type ASL & TC stem loop mini substrate, with
the standard deviation (SD) also reported as percent of wild-type. All
of the listed mutants are in the context of the ASL & TC stem-loop
mini-substrate.
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be a reason that the V stem-loop of tRNA
Ser(UGA) does
not substitute for the TC stem-loop when combined
with the ASL. The V stem-loop in tRNA
Ser(UGA) is
predicted to have only 3nt in the loop. The fact that the
TC stem-loop is separated from the ASL by 4nt in the
mini-substrate and the V stem-loop has no separation,
may also be a factor in why the TC stem-loop can par-
ticipate in creating a mini-substrate that is recognized by
hPus1p.
The only  synthase in the TruA family that has been
crystallized is bacterial TruA (see above) and the struc-
tures were obtained in the presence of substrate tRNAs
(46,47). TruA is a dimer and makes contact with the ASL
(positions 38–40 are modiﬁed if a U is present at those
sites), the D stem, and the ‘elbow’ where the D and TC
loops interact. The V loop or stem-loop and the acceptor
stem did not interact with TruA (47). In this report the D
stem-loop of tRNA
Ser(UGA) was found to be dispensable
for hPus1p activity, as was the acceptor stem, but the
absence of the V stem-loop from the tRNA does reduce
the amount of  formed. In this tRNA substrate, the TC
stem-loop appears to be the more critical component for
recognition by hPus1p. Therefore, even though there is
considerable homology between TruA and hPus1p, the
substrate contacts with the protein are probably different.
Yeast Pus1p has been shown to be a monomer when
bound to tRNA (30) and it is reasonable to assume the
substrate/enzyme interactions will be fundamentally dif-
ferent between TruA and Pus1p. Crystal structures for
any of the Pus1p proteins in the presence of tRNA sub-
strates will go a long way towards reconciling these
differences.
With what appear to be relatively lax requirements for
substrate recognition in tRNA
Ser, what prevents other
uridines, such as those at 39, 43, 44, 63, or 70 in
tRNA
Ser (Figure 1A) from being modiﬁed by hPus1p
in vitro? Modiﬁcations in the ASL (26, 27, 28, 30) of all
natural substrates of Pus1p are only found on the 50 side
of the stem. This speciﬁcity is most likely due to the pres-
entation of this side of the ASL to the enzyme’s active site
cleft, in much the same way the opposite side of the stem is
presented to TruA for modiﬁcation of positions 38–40
(47). This ﬂipping of the orientation of the substrate in
the active site cleft could explain why the TC stem-loop
is a critical part of the recognition motif for hPus1p rather
than the D stem-loop. These other sites that have uridines
in a stem are not recognized because they are not pre-
sented in a conformation compatible with placing the
uridine in the active site.
Additional natural and mini-substrates will need to be
studied to reﬁne the parameters of hPus1p substrate rec-
ognition to construct a recognition site that can be used
to narrow down the possible modiﬁcation sites in SRA,
a relatively large, non-tRNA substrate of Pus1p,
where most of the actual  residues have not been
identiﬁed (37,38), or to identify additional substrates.
The known substrates of Pus1p may just be the tip of
the iceberg of actual RNA substrates for this enigmatic
enzyme.
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